Japanese Journal of Medicine
Online ISSN : 1881-123X
Print ISSN : 0021-5120
Hepatocellular Carcinoma and Bladder Cancer as Complications Following Five Years of Chemotherapy for Acute Myeloblastic Leukemia
Yuichi HIROTA, Isao MATSUMOTO, Teijirou ASO, Seiji KONDOU, Wataru IKEMATSU, Hisako HINO, Saburou NISHIURA, Kenji YONEDA, Tsuneo SHIRAISHI
Author information
Keywords: Acute myeloblastic leukemia, Secondary cancer
JOURNAL FREE ACCESS

1990 Volume 29 Issue 2 Pages 203-207

Details
Download PDF (2485K)
Download citation RIS

(compatible with EndNote, Reference Manager, ProCite, RefWorks)

BIB TEX

(compatible with BibDesk, LaTeX)

Text
How to download citation
Contact us
Abstract

Acute myeloblastic leukemia (AML) was diagnosed in a 54-year-old male, a chronic hepatitis B surface antigen (HBsAg) carrier, in June, 1983. Prompt remission was achieved, and maintenance and intensification chemotherapy were given for five years. He was readmitted in March, 1988 because of a mass in the liver and was diagnosed as having hepatocellular carcinoma (HCC). Curative right segmentectomy was performed in May, 1988. In December, 1988, transitional cell carcinoma of the bladder was discovered, and resected transurethrally. These secondary neoplasms, HCC and bladder cancer, were thought to be associated with the long-term chemotherapy given for the AML.

Content from these authors
© The Japanese Society of Internal Medicine
Previous article Next article
Favorites & Alerts

Recently viewed articles
Successor

Internal Medicine

Share this page
feedback
 Top